Such co-culture model systems for autologous HBVs+ HCC organoids and CD39+ HBV-CAR-T cells or CD39+ personalized tumor-reactive CD8+ T cells were also modeled to assess their anticancer efficiency (75). The gene discussed is ENTPD1; the disease is hepatocellular carcinoma.